Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank62
3Y CAGR+60.1%
5Y CAGR-24.0%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
+60.1%/yr
Annual compound
5Y CAGR
-24.0%/yr
Recent acceleration
Percentile
P62
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $44.22M | +220.8% |
| 2024 | $13.78M | +130.7% |
| 2023 | $-44.86M | -516.0% |
| 2022 | $10.78M | -91.8% |
| 2021 | $131.51M | -24.7% |
| 2020 | $174.75M | +461.6% |
| 2019 | $-48.32M | -0.6% |
| 2018 | $-48.05M | -179.2% |
| 2017 | $60.70M | -54.2% |
| 2016 | $132.63M | - |